CXCL8 and central nervous system cancer: Consistently, we found that inhibition of IKK (TPCA-1) and MEK (U0126) substantially inhibited P2Y11 receptor-driven IL-8 production, both in the recombinant glioma cell line and in primary M2c macrophages (Figure 8).